Delivery Order SPE2DB22D1106-SPE2DB25FEZV5
- Not listed
- The Defense Logistics Agency awarded a $2,086.50 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Nayzilam 5 mg nasal sprays. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nayzilam 5 mg nasal sprays. The contract has a firm fixed price, with a ceiling value of $2,434.06, and a period of performance through May 6, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,464.82 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Nayzilam 5 mg nasal sprays. This award was made under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that DLA has with AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,336.03 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply NAYZILAM 5 MG NASAL SPRAYS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.94, is for the supply of 4,567,875,332 units of the medication NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a for-profit...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation, a $1,008.39 firm fixed price delivery order contract to supply 4564168540 units of the specialty pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NAYZILAM 5 mg nasal sprays, with a ceiling value of $2,388.74 and a period of performance ending on April 1, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide NAYZILAM 5 MG NASAL SPRAYS. The contract has a firm fixed price of $1,435.68 and a period of performance through June 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,174,376 units of the medication NAYZILAM 5 MG NASAL SPRAYS. The total ceiling value of the contract is $10,634.56, with a period of performance through May 8, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.00 Firm Fixed Price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS. The award is not associated with a set-aside program and has an ultimate completion date of May 6, 2025. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZV5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nayzilam 5 mg nasal sprays, valued at $1,391.00. This delivery order is issued under a firm fixed price contract with an ultimate completion date of July 28, 2025. The contract does not utilize a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this framework, AmerisourceBergen Drug Corp delivers essential pharmaceuticals and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the current delivery order fulfilling acute seizure management needs for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/25/25 |